Dietary omega-3 fatty acids aid in the modulation of inflammation and metabolic health
Citations Over Time
Abstract
This article focuses on the role of omega-3 fatty acids as precursors for lipid signaling molecules known as oxylipins. Although omega-3 fatty acids are beneficial in autoimmune disorders, inflammatory diseases and heart disease, they are generally underrepresented in the American diet. A literature review confirms that the consumption of omega-3 fatty acids - whether in food sources such as walnuts, flax seeds and fatty fish (including salmon and sardines), or in supplements - is associated with decreased morbidity and mortality. This growing body of evidence, including the results of a recent study of patients with kidney disease, highlights the need to measure omega-3 fatty acids and their oxylipin products as markers of metabolic health and biomarkers of disease. In addition, there is substantial evidence of the need to increase the omega-3 fatty acid content of American diets to optimize metabolic health.
Related Papers
- → Advances in Our Understanding of Oxylipins Derived from Dietary PUFAs(2015)772 cited
- → Dietary n-3 long chain PUFA supplementation promotes a pro-resolving oxylipin profile in the brain(2018)77 cited
- → The Brain Oxylipin Profile Is Resistant to Modulation by Dietary n‐6 and n‐3 Polyunsaturated Fatty Acids in Male and Female Rats(2019)39 cited
- → Spleen Oxylipin and Polyunsaturated Fatty Acid Profiles are Altered by Dietary Source of Polyunsaturated Fatty Acid and by Sex(2020)11 cited
- → Profiling of Oxylipins as Markers of Oxidative Stress in Biological Samples(2024)1 cited